tiprankstipranks

XBI ETF Price & Analysis

Compare

XBI ETF Chart & Stats

ETF Overview

SPDR S&P BIOTECH ETF

The SPDR S&P Biotech ETF, with the ticker XBI, offers investors a targeted opportunity to engage with the dynamic and innovative biotechnology sector within the broader health care industry. This sector-focused fund is designed to provide exposure to a diverse array of biotechnology companies, ranging from established leaders in the field to emerging innovators poised to drive the next wave of medical breakthroughs. The ETF's unique equal-weighted structure ensures a balanced representation across its holdings, minimizing single-company exposure and allowing investors to benefit from the collective growth potential of the biotech landscape. With advancements in gene editing, personalized medicine, and novel therapeutic approaches, the biotechnology niche continues to be at the forefront of transformative health care solutions. By investing in the SPDR S&P Biotech ETF, investors can tap into this cutting-edge sector, gaining access to companies that are pushing the boundaries of medical science and innovation.

SPDR S&P BIOTECH ETF (XBI) Fund Flow Chart

SPDR S&P BIOTECH ETF (XBI) 1 year Net Flows: -$868M

XBI ETF FAQ

What was XBI’s price range in the past 12 months?
XBI lowest ETF price was $81.14 and its highest was $105.47 in the past 12 months.
    What is the AUM of XBI?
    As of Feb 17, 2025 The AUM of XBI is 6.03B.
      Is XBI overvalued?
      According to Wall Street analysts XBI’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does XBI pay dividends?
        XBI pays a Semiannually dividend of $0.002 which represents an annual dividend yield of 0.14%. See more information on XBI dividends here
          How many shares outstanding does XBI have?
          XBI has 66,375,000 shares outstanding.
            Which hedge fund is a major shareholder of XBI?
            Among the largest hedge funds holding XBI’s share is Sivik Global Healthcare LLC. It holds XBI’s shares valued at 18M.

              XBI ETF Smart Score

              For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

              Top 10 Holdings

              Name
              Weight %
              Gilead Sciences
              2.67%
              Abbvie
              2.63%
              Insmed
              2.54%
              Amgen Inc
              2.53%
              Natera Inc.
              2.46%
              United Therapeutics Corp.
              2.43%
              Alnylam Pharmaceuticals
              2.39%
              Biomarin Pharmaceutical Inc.
              2.33%
              Vertex Pharmaceuticals Inc.
              2.33%
              Incyte
              2.31%
              Total24.61%
              See All Holdings
              Popular ETFs
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis